Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Life Science

• Publication date

  1998-11-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0024-3205(98)00499-8PMID 9851310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ocular activity of topically administered anandamide in the rabbit.

  1997cited by this paper
• Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues.

  1997cited by this paper
• Effects of Topical alpha-Substituted Anandamides on Intraocular Pressure in Normotensive Rabbits

  1997cited by this paper
• Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits.

  1997cited by this paper
• Modified β‐Cyclodextrin (SBE7‐β‐CyD) with Viscous Vehicle Improves the Ocular Delivery and Tolerability of Pilocarpine Prodrug in Rabbits

  1996cited by this paper
• Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.

  1996cited by this paper
• Effects of topical anandamides on intraocular pressure in normotensive rabbits.

  1996cited by this paper
• Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits.

  1995cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994cited by this paper
• (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.

  1994cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Ocular Hypotensive Effect of Marihuana Cannabinoids: Correlate of Central Action or Separate Phenomenon?

  1986cited by this paper
• Disposition of ophthalmic timolol in treated and untreated rabbit eyes. A multiple and single dose study.

  1984cited by this paper
• Marihuana smoking and intraocular pressure.

  1971cited by this paper

• Is fat the future for saving sight? Bioactive lipids and their impact on glaucoma.

  2023cites this paper
• Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes

  2022cites this paper
• Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma.

  2021cites this paper
• Uso terapêutico da maconha em pacientes com Glaucoma: uma revisão / The therapeutic use of marijuana in patients with Glaucoma: a review

  2020cites this paper
• The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice

  2017cites this paper
• Cannabinoid Regulation of Intraocular Pressure: Human and Animal Studies, Cellular and Molecular Targets

  2017cites this paper
• The arguments for and against cannabinoids application in glaucomatous retinopathy.

  2017cites this paper
• Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis

  2017cites this paper
• Neuroprotective Strategies in Glaucoma.

  2016cites this paper
• Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure

  2016cites this paper
• ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA

  2016cites this paper
• The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review

  2016cites this paper
• A GPR18‐based signalling system regulates IOP in murine eye

  2013cites this paper
• Heat shock protein 90 is an essential molecular chaperone for CB2 cannabinoid receptor–mediated signaling in trabecular meshwork cells

  2012cites this paper
• Indirect Sympatholytic Actions at β-Adrenoceptors Account for the Ocular Hypotensive Actions of Cannabinoid Receptor Agonists

  2011cites this paper
• Aplicaciones de los cannabinoides en glaucoma

  2011cites this paper
• Ocular hypotensive effect of oral palmitoyl-ethanolamide: a clinical trial.

  2011influential citation
• A REVIEW O CHITOSA BASED AOPARTICLE AS A EW OCULAR DRUG DELIVERY

  2011cites this paper
• Nonpsychotropic Cannabinoids, Abnormal Cannabidiol and Canabigerol-Dimethyl Heptyl, Act at Novel Cannabinoid Receptors to Reduce Intraocular Pressure

  2011cites this paper
• Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes

  2011cites this paper
• [Cannabinoid applications in glaucoma].

  2011cites this paper
• Cannabinoid applications in glaucoma

  2011cites this paper
• Emerging drugs for ocular hypertension

  2011cites this paper
• Biodegradable hybrid polymeric membranes for ocular drug delivery.

  2010cites this paper
• Physical and functional interaction between CB1 cannabinoid receptors and β2‐adrenoceptors

  2010influential citation
• IOP as a Target – Inflow and Outflow Pathways

  2008cites this paper
• Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.

  2008cites this paper
• N-arachidonylethanolamide-induced increase in aqueous humor outflow facility.

  2008cites this paper
• Comparison of Topical and Intravenous Administration of WIN 55-212-2 in Normotensive Rabbits

  2008cites this paper
• Aqueous humor outflow effects of 2-arachidonylglycerol.

  2008cites this paper
• Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.

  2008cites this paper
• Topical WIN55212-2 Alleviates Intraocular Hypertension in Rats Through a CB1 Receptor Mediated Mechanism of Action

  2008cites this paper
• Cannabinoids: A novel treatment strategy for retinal neurodegenerative disorders

  2008cites this paper
• Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716)

  2008cites this paper
• Molecular and cellular changes induced by the activation of CB2 cannabinoid receptors in trabecular meshwork cells.

  2007cites this paper
• Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.

  2007cites this paper
• Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug

  2007cites this paper
• Neuroprotective and Intraocular Pressure-Lowering Effects of (–)Δ9-Tetrahydrocannabinol in a Rat Model of Glaucoma

  2007cites this paper
• Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration.

  2006cites this paper
• Ocular Hypotensive Effects of an Intratracheally Delivered Liposomal Δ9-Tetrahydrocannabinol Preparation in Rats

  2006cites this paper
• Effect of Sublingual Application of Cannabinoids on Intraocular Pressure: A Pilot Study

  2006cites this paper
• Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility.

  2006cites this paper
• Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation.

  2006cites this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cites this paper
• R(+)-Methanandamide and Other Cannabinoids Induce the Expression of Cyclooxygenase-2 and Matrix Metalloproteinases in Human Nonpigmented Ciliary Epithelial Cells

  2006cites this paper
• CB1 cannabinoid receptor-mediated changes of trabecular meshwork cellular properties.

  2006cites this paper
• Antagonismo del Sistema Endocanabinoide: Implicaciones en el tratamiento de la obesidad, síndrome metabólico y adición a drogas

  2006cites this paper
• Finding of endocannabinoids in human eye tissues: implications for glaucoma.

  2005cites this paper
• Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork.

  2005cites this paper
• On the importance of anandamide structural features for its interactions with DPPC bilayers: effects on PLA2 activity Published, JLR Papers in Press, June 16, 2005. DOI 10.1194/jlr.M500121-JLR200

  2005cites this paper
• ON THE IMPORTANCE OF ANANDAMIDE STRUCTURAL FEATURES FOR ITS INTERACTIONS WITH DIPALMITOYLPHOSPHATIDYLCHOLINE BILAYERS : EFFECTS ON PLA 2 ACTIVITY

  2005cites this paper
• CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility.

  2005cites this paper
• Cannabinoids and glaucoma

  2004cites this paper
• Glaucoma therapy : current issues and controversies

  2003cites this paper
• Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys.

  2003cites this paper
• A3 adenosine and CB1 receptors activate a PKC-sensitive Cl- current in human nonpigmented ciliary epithelial cells via a G beta gamma-coupled MAPK signaling pathway.

  2003cites this paper
• A3 adenosine and CB1 receptors activate a PKC‐sensitive Cl− current in human nonpigmented ciliary epithelial cells via a Gβγ‐coupled MAPK signaling pathway

  2003cites this paper
• Pathogenesis of Glaucomatous Optic Neuropathy (GON) : ATHOGENESIS OF LAUCOMATOUS EUROPATHY Josef Flammer

  2003cites this paper
• EMGT (Early Manifest Glaucoma Trial)

  2003cites this paper
• Topically administered CB(2)-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits.

  2003cites this paper
• Anandamide prodrugs. 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide.

  2003cites this paper
• Cannabinoids in the treatment of glaucoma.

  2002cites this paper
• Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.

  2002cites this paper
• Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.

  2002influential citation
• Cyclodextrins in Eye Drop Formulations

  2002cites this paper
• Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides.

  2002cites this paper
• Cyclodextrins in topical drug formulations: theory and practice.

  2001cites this paper
• Complementary and alternative medicine for glaucoma.

  2001cites this paper
• The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

  2001influential citation
• Effects of Topical Anandamide-Transport Inhibitors, AM404 and Olvanil, on Intraocular Pressure in Normotensive Rabbits

  2001cites this paper
• Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.

  2001cites this paper
• Cannabis : quels effets sur le comportement et la santé ?

  2001cites this paper
• The synthetic cannabinoid WIN55212‐2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies

  2001cites this paper
• Pharmacology of the Intraocular Pressure (IOP) Lowering Effect of Systemic Dexanabinol (HU-211), A Non-Psychotropic Cannabinoid

  2000cites this paper
• A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits

  2000influential citation
• Identification of the Role of Endogenous Cannabinoids in Pain Modulation: Strategies and Pitfalls

  2000cites this paper
• Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2.

  2000influential citation
• Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina.

  1999cites this paper
• Synthesis and release of docosahexaenoic acid by the RPE cells of prcd-affected dogs.

  1999cites this paper
• Localization of cannabinoid CB1 receptors in the human anterior eye and retina.

  1999cites this paper